-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Q6p5F45Lpj3yw5u1fW6eZ9r5IODRJpx0Zf5gVdLSg3rHSOCn5Vlpc3s0alePiO9F
 K2iQ97/6CiDuHcd/rJPEUA==

<SEC-DOCUMENT>0001193125-10-279614.txt : 20101214
<SEC-HEADER>0001193125-10-279614.hdr.sgml : 20101214
<ACCEPTANCE-DATETIME>20101213190934
ACCESSION NUMBER:		0001193125-10-279614
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20101208
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20101214
DATE AS OF CHANGE:		20101213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARCA biopharma, Inc.
		CENTRAL INDEX KEY:			0000907654
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				363855489
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22873
		FILM NUMBER:		101249128

	BUSINESS ADDRESS:	
		STREET 1:		8001 ARISTA PLACE
		STREET 2:		SUITE 200
		CITY:			BROOMFIELD
		STATE:			CO
		ZIP:			80021
		BUSINESS PHONE:		720-940-2200

	MAIL ADDRESS:	
		STREET 1:		8001 ARISTA PLACE
		STREET 2:		SUITE 200
		CITY:			BROOMFIELD
		STATE:			CO
		ZIP:			80021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVELO INC
		DATE OF NAME CHANGE:	20030203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HYSEQ INC
		DATE OF NAME CHANGE:	19970610
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act of
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (Date of Earliest Event Reported): December&nbsp;13, 2010 (December 8, 2010) </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>ARCA biopharma, Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact Name of Registrant as Specified in Charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>000-22873</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>36-3855489</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or Other Jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of Incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(I.R.S. Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8001 Arista Place, Suite 200,
Broomfield, CO 80021 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of Principal Executive Offices) (Zip Code) </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(720) 940-2200 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(Registrant&#146;s Telephone Number, Including Area Code) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Not
Applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Former Name or Former Address, if Changed Since Last Report) </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.
below): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;1.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Entry into a Material Definitive Agreement </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On December&nbsp;8, 2010, ARCA biopharma, Inc. (&#147;ARCA&#148;) and the University of Cincinnati agreed to extend the term of the Exclusive Option
Agreement dated December&nbsp;2, 2009 (filed as Exhibit 10.27 to ARCA&#146;s Annual Report on Form 10-K for the period ended December&nbsp;31, 2009) that gave ARCA an option to license exclusive, worldwide rights to certain patent rights relating to
genetic polymorphisms of adrenergic cardiac receptors.&nbsp;The rights include those for developing and commercializing diagnostics for the receptor polymorphisms that may indicate which patients will respond most favorably to Gencaro. The period of
the option has been extended from December&nbsp;2, 2010 to December&nbsp;31, 2010.</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The letter in regard to the agreement term extension is
filed as Exhibit 10.1 to this Current Report on Form 8-K, and the description of the extension is qualified in its entirety by reference to such exhibit. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial Statements and Exhibits </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(d) Exhibits </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:39pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Letter in regard to agreement term extension, dated December&nbsp;8, 2010, of the Exclusive Option Agreement dated December&nbsp;2, 2009 between ARCA biopharma, Inc. and the
University of Cincinnati.</FONT></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dated: December&nbsp;13, 2010 </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARCA biopharma, Inc.</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(Registrant)</FONT></P></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Christopher D. Ozeroff</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Name: Christopher D. Ozeroff</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title:&nbsp;Senior&nbsp;Vice&nbsp;President&nbsp;and&nbsp;General&nbsp;Counsel</FONT></TD></TR></TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXHIBIT INDEX </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:39pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Letter in regard to agreement term extension, dated December&nbsp;8, 2010, of the Exclusive Option Agreement dated December&nbsp;2, 2009 between ARCA biopharma, Inc. and the
University of Cincinnati.</FONT></TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>dex101.htm
<DESCRIPTION>LETTER IN REGARD TO AGREEMENT TERM EXTENSION, DATED DECEMBER 8, 2010
<TEXT>
<HTML><HEAD>
<TITLE>Letter in regard to agreement term extension, dated December 8, 2010</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 10.1 </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g127347g80m31.jpg" ALT="LOGO"> </P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>8001 Arista Place, Suite 200 </I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Broomfield, CO 80021 </I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Phone: 720-940-2200, Fax: 720-208-9261
</I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">December&nbsp;8, 2010 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Geoffrey Pinski </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director of Intellectual Property </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">University of Cincinnati </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Office of Intellectual
Property </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">51 Goodman Dr, Suite 240 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cincinnati, Ohio 45219-0829 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dear Geoffrey,
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">When countersigned by the University of Cincinnati, this letter will extend the Exclusive Option Agreement between ARCA
biopharma, Inc. and the University of Cincinnati dated December&nbsp;2, 2009 to December&nbsp;31, 2010. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Please sign below
indicating your agreement to the above. Feel free to contact me if you have any questions </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="100%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Best regards,</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Christopher D. Ozeroff</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher D. Ozeroff</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">SVP and General Counsel</FONT></TD></TR></TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>ACCEPTED AND AGREED</U>:
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">UNIVERSITY OF CINCINNATI </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Geoffrey Pinski</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Geoffrey Pinski</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;December 8, 2010</FONT></P></TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g127347g80m31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g127347g80m31.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`;`$D`P$1``(1`0,1`?_$`-(```$#!`,!````````
M```````("0H#!08'`00+`@$!`0`"`@,!`0````````````$"`P8'!0@)!`H0
M```&`0,"`P0'!`8&!@L```$"`P0%!@<`$0@A$A,4"3%!82/P49$B,A46<8%"
M"K%2<C,D%\%B);<8.%.V-W=X.8*EM<75)F9VUI=8$0`!`P($`P,&"`</!0$`
M```!``(#$00A,04&01('46$B<8$R$Q0(D;'10E)B(PFA<K)3DR1TP8*2HM(S
M0V.STY34%39VE196%S<9_]H`#`,!``(1`Q$`/P"?N([`(C[`#?[-$5EG+)`U
MF+=S=BEF$)#L2>([DI1TBR9H%]P'77.0G><>A2AN8P]``1UX?7]PZ%M72IM=
MW+>6UAHT#>:2>>1L43!WO>0*G(#-QP`)P7Z+6TNKZ=MK91OEN7F@:P%SCYA^
M'L25)CG7Q_BW:C5O*66=(F82B]A:VZ.R.)>FZ2LBK&G5*/N,4@@/UZ]0];]_
MSW=M(O76=M=ZGJ#6DCUEK92&(TXM=,82X=A:"#F,%V#;=*-X7$8D?'!"3\U\
MHYO.&\U/A5K#GW@HWX6U]']E81_^+:\,?O$?=^&;-P?X)G^87Z3TAW8,S:?I
M3_(78+SQPB<ISE97XQ$P**A@K"&Q`,8"%$W^UNFYS`'[1UDW[P_H"]CI&1;A
M+&`%Q]A9@"0T$_K'$D#SK`])-U-(!=9U/]:?Y"HFY\8,)[6M^Z?_`$P@/_O;
M6'_Z)^[[]#<'^!;_`)A9#I%NL_.L_P!*?Y"X3Y]X&4.4IB7E(IA`!54K!!(0
M!_B,"4DJJ(!_JE$?AK=%]X;[OLD@8\:\QA/I.L00.\\LSG4\C2>Y'=(=VM!/
MZH2.'K?E:!^%**QWF7&N56JCBBVIA-*MR`H\C0\1G,,2#L'>[B7I&[])+N';
MQ/#%,1Z`;7LQTVZT=,>KEH^ZV!J]M?R1-!DA'-'<1`\9+>4,F:*FG/R<A.3B
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M:FB@BF91550P]"D33*(B/N`-:;BXAM+=]U<O;';1L+WN<:!K6BKG$\``"2>Q
M9,8Z1XC8"7N(``S).``3!'(C.TWFVYO'`.G"%(B'BS:H0(',1J5JD<R19MX@
M`@1:7E"E\0QS`(I)F*F78`'?^>?WE_>"U[KMO>>X]=)'L"RF>S3K0$B/U;26
M^U2LR?<3CQ\SJF-A;$R@#B[V[V5M*UVKIC6EH.K2M!FD^=4_T;3P8S*@](U)
MS6FXZ$7=*`!B&W';[H@/0!Z]0'V[@._U:]>+:QNKR;U$+3S5QP\_Q+E$UTR,
M9A;?BL>J/(?\P(B(C'NDF;T"E#[J3T%58]P?8-]C*HJI"/N$"![PUW%HW2NZ
MU70FZH&$OMIA%*`/F2\SH9#Y7-DC).7V8XA<9N==;#<F%QP>WF;Y6T#A\%#\
M*S6)QH9Q$69QX.X,(Z.7$>WJ45IN.;;^WW@J/UZ[%T3HR;C1=6N#'A!:PNRR
MYKN!GQ..:\/<[AY+F!@/I/<,^QCBK`EC8SE94QDC>59-5Y)\?MZ%:-"@80$1
MV^\X7,FB7_75#7%8^CLD]RZ1S"VSMHGSRD#^CB%:>61Q9$WZTC5^X[A:QH`/
MVCW!K?*?D%7'N"U'-5M9!1104^P1,<X]A=B@(B)A``Z`!0$>@>X-=*ZQH6H:
M;,^29OA+B2*4`J:F@R`'#L"Y-:7S)&@5J`%9H.<L-+GH^P5Z2>0<]$KD<Q\B
MS.9)=(P"`]I@_"LV7+]U1(X&35(.Q@$!U=M;EW#LS7K;<^V+J>PW!:/#XIHR
M6O:<Z$9/C>,'QN!9(PD.:05^J[M++5+1]G>L;+:2"CFG$'Y".!&(.(*?IP#E
MI#,^-(>WBDBUF4SK0]G8(?W+.?CRI^:%`!$3%:/D54W"(#N)4U0+N(E$=?T.
M^[IUCM^N/2VRWF6,AUII=;WT+?1CNX0WUG+7$1R-<R:,&I#)`TDEI*]0MX;=
M?MC79=-J76QH^)QS=&ZM*][2"T]XKQ6Z==Z+BZ-$1HBQZW6J!HM4L]WM3]*+
MK%.K\S:+%)+"`),(2`CG$I*.U!$0#M09-3FVWZ[;:(F+_1Z]37('-7*O*"@9
M<EFRK]O,FROA&()&Q<8I7\4/I96">4KO8MFJTJ>JBM%JBNX%9R<[U43*"4``
MI9N;05"?QT6"-$5CLX60:U8@IHPQ;@,%+A4S6('8UXMF&/<!`FG@8?XX84)3
MPO->!\[P.[L^]MHBC^\BN9OK4\0:A*Y)ROQJXHY#QI`$24L=TQ<[O<M'U]J8
MZ:(R4U&FM\?9HN*\4X`=T=@=NCW@*AR!UT6RC2D)0O\`,6\P+?,P53I_&'",
MW;;+*Q\!`0\:MDF6D)N<EW:+"+C(N+;3B#AP\?/5R)II@H83&,'4-6BO($Y[
M&Y1]?RPQR<R7CAPLJ`.$2.TJY8+=+GFB$4)W%:+A'WZ69MW0`<.XJC@O:)1`
M1WU,%CX$FRZ^M)S3X?9!BJ'SVX005>1E2**Q]@Q?:7L>A.L&RA$WLG4WTJ]N
M%.M1F0JE%5LG*-%4A,4%/"[BB+R*\H.13X_%3E[@GF=C8N3L$VS\]BVKE.-L
MM?DV_P"57&D3:B/F"PMNKZBBJT:[41W.BJ0RK1V0!.W65*`B!8$$9I36BB-$
M37/.+U;>+?")=[3YJ0>Y6S0W0*J.):`Y9*/H05"%4;GOME<F-"TI%9,>X$5/
M,2)B"!RM#$$#:+(-)\B0?B7D]ZU7/9JVN>",<83X@X2ENY6`R!DJ$D)^3FXU
M0QO">P2=E:2DG:$3$`>QXV@&4>J(?<6'565&-SQ*4$[XB>LHFS%]'^J'07,]
MV=P1+[CS5F=>%4!`X)>>1AG[U-(3;E$_E3"!?X1]FI@I5O8FZ.2'-WUP^`+E
MJ\Y`1V(LBT!T])'Q>466-X^:H$FZ5,<C9D^G*6O2I*MR;SPQ\)"4:,U%A`?"
M\78=54!KLDZ[Z1OJ"9)Y_P",<N63*U9HE8M6,KY#5I%O06LVSC7T'-UI"69R
M#Y"=F9I<C\\@B[3^6H5+PTR[%[MQU%BX4*=NT6*-$0'7H'M'1%'J5]6"PJ>L
MDRXNMK,Q_P"&4BJG'IRP+&Q9@<9V4:'>A;@G!;C+`9O=P+5P0*Y!H)0,IX8G
M$#:JSY?#WJ0J/3H/M#46"-$55'\?[AT1=O1%J//KQPPPEE9VU4%)PE0;/X:A
M1$#$%2)<I&$!#80'L..NG?>%OKG3>A>[KVS<67+-O7W*1F*V[VFG?0FBY%M&
M)DVZ-/CD%6&[BJ/WX*CYPS`72Q"@7IT*4`]P!L'^C7\VUK;ONIF6T0QP7N-<
M2B-A)S2K,=5*.F/+Q4FLG'N%.U.)F%P$&S=P8?EL980*)@C'!AV*L`"9J<>X
M0%,3`'N!TFV'IFMQQ:3K+F6TYH+>Z?@QCCE#<'\P\GPR8FW=XB#$7-'6^NZI
M/;$SVX+V?/8,R.+F?6'%OSQ]:B5%CNAJ1=I<T^RL%&!)]B[@'R2I`$4EE2E=
M1,@@<!%-<$))JD=)0HB0X;[#L.O<+IML%^D;NDV/N6V?;1ZA;R6DK2,6N<!)
M;S,/HNY9HXWQO:2UP.!(*Z^UC5A<6`U*RD#W0O$C2.(&#FGB*M)!!Q'8M@U[
M&CEA7\IL7K3M=M8UBR#8@B50[.0"4%1$0+]XBJ;0AB_ZI@UV)MKIA?:=MO=V
MGW\1]MAM8HAA@3%+[15G:US8VN!'!P7B+O6HI;RPDB=]FY[CY.9O)CW@DA8K
M/T8M:Q\W!9`"2]TD$5U2B795M`1(>.U;"7;<!?/UDUCA[^P@>T-<3W!L8;4Z
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M<WET)6K/DTQ'[I%W+.6;+'*'N,H1HF`_7VAKZC_=F7DSM#W?I[G$VS+VPD:.
M`=)%.UQ`[7")E?(%TOUKC:+G3I@/&8Y6D]H#F$?!4_"G)]?41='(T1&B)EWU
MK<M65+!^,^'>+ERJ9@YOY/KV(89F17L5;T@DO%*6Y^Y,F(K-HUX\>,&#A3MV
M\HY<#U[!#19-&->`44_A'EF?X)^H)CR;N(J0I<>97FL.9?:&[BIHUJ6EG6/[
MJ*R9^SQ&\0N8LDGW`&YF:9NG356P@$+T40$I@`Q#%4(8`,0Y!`Q#D,`&(<IB
MB(&*<H@("'00U%I7.B(T1)VY>LVS_B;R?9O$2.&KCCWF5-9%0`,10G^7EA-L
M8!`0_$4!T5&:@1^E@DFX]0KAL5=,JI?\WX9?M.'<'C-X*:<H*;#_`!I+I%.4
M?<8H#JK:[(KT9=1:4U=ZS^&JWEWT\\[/I>-;N9_$<.UR]2I0Z9!=PLO4'S=6
M7.U6$OB)I2M5</V:Y`$"G(MN(")2[%DTT*BO^BIG>RX7]0#$4#&/G1:KG-P^
MQ'>(4BAO)RB$K&2$E57ZR'5,7T!:6#=1%7;O3167(`@54X#5FX8*?CJ+4F//
M6=]2F2X=8]BL,89E4FO(G+L.[>(SB()KN,4X^%56.=7)-)0#I%M$Z\35:0H'
M*)43HN'0@(H)E4+)K:YIGKT4/3GC^6%ZL'*_D-'K6W%%#MJR%=@[,HO)DR_E
MDATY67F+4L^,LM/5RI*N4E79%S'+)RBQ4U1.F@X3/5FYU,.*FBI))H))((II
MHH()D1112(5-)%%,H$3223(!2)I)D``*4H```&P:BU+[T18K>:-3\F4^R8^R
M#6XFX4FX1+N"LU9G6I'L5,Q3Y,4W#1VW4#ZA`Q#E$JB2A2G(8IRE,!,LDQ!Z
M5V`)+A%STYZ<2T1EWV/Y2G8KS)BF<?HN%2R5&--62-CD'4D=%-!W-086?\L=
M&`0,LK'F5VV,&U6;L6@J03J+!&B)+'-GD?%\2^+&:,]R"K<'M(ISX:FT<&(!
M)6]S0D@Z1%^&<0%8CJRR#852EW$&Y5#>PHZ*@5-%YZ>8\9YKX[Y!H4[D)5Y%
M9)NU-QUR8KD\95<9!17((_K:$FG2Z@$4+/,IY!3SI=Q%)XD<HCTU5NPX+T5N
M+&<XGDQQSPUGB&%($,F4*"L+]LC^"-L0M@96N&$`$=CPMF:.VIOBEJ+210T6
M_=%%51_'^X=$7;T1:9Y$AO@K+0?70K('_JU;72/O*&G0#>)/_CU[_8N7)MF?
M[LT[]LB_*"9'H*8%50*NS;/VX"&[=R0_L$?O"DY0,BZ0,/UE/MO[0'7P(Z;`
M27[6W4,-S:!W\W(#Q./+(PMD8>-6NI7-I7M+K3O`>1SF/[0?C!JT^<>=+JH5
M.I]B311CYI6MRI^T"QEC(1U&.%#;!V,YUJ1`R8F$=@(X0*;W=QAU](-@;)V7
MN.&.STR_?I6KN``@O`)('D\([N,,(/`-FA!X!SBNG=6U+4K-Y?-$)X!\Z.H<
M/*PU^%KO,%ONYVU3&==K<-8X^*G[L#DY::J+E186D6Q\(32D@JF"+DS1BLH5
M))(3!XYM@'8"".O87>N\7]*]MZ7H6ZK>SU'?K93_`*:[G<XQP1!I,\SAR/,<
M3BUC(R1ZUW*#0,<Y<3TW31K=Y/=63Y(=+I]M@!5SOF-S%7#$FGAQ[0J%6F+S
M9EBNWMFDQ55-W"FU4(S;%$0_"FT;$31[``=MA`1V]HCKQ^T]>ZA[KN/:[S5K
MOUSS7EC(BC'<&,`;3A0@X9DK*_MM+L08XH(^4<3B?A.*VRDHJG(L"V1HSEI)
MNDLC`R+TH)^"]5+N@BZ*4/+B598I2E6[.\@C\=P[D@FFBU6W9NRW@O-6C8]M
MG-+X>65PJQD@`Y*/<`&R<O,P^6HX^YK3"_V)SHX30O:W&HXD<<!6HK0I/^0J
M`1%=Y.9`M;-J_D#G<FCXM`\Q-.1$/NI(H'.U:-4"%V(0QS@F4H;!OMMKUWZA
M].VVMU-N#J/K$$-_<N+S!;L-S=2=C6M)CCC8!X6N>[D:T4J:4/+M(U<O8VUT
MFW<Z)F',X\C!WDT))XD`5*0KDA*+2%8L+%BT2*)NUW(K%D913ZC&,5)%@U$0
M]R2/<7^N/MU\\>L%MI5L7_\`;UGZB(92S.$UP>_T6PQ^2./F'YQV:[;T"2=P
M!N9.9W8T<K1^$N/G-.Y*9]/(G8&8`'?<7-.$=_K$E@W'[=>V7W91<;+>7,:N
M]HT[\B[7">M!J[33]6;XXTY1KZH+HU&B+D`W$`#VB.WVZ(H\O'Q]_P`=WK,Y
MIS\8?S?"_`ZIGQ#B]<0*YB7>1I-:8@9"7:&_N5%5)$;"[*J7<WA(,C;[`4=.
M"S.#:<2F;?7IX[EP[SCF+]&,/*U+D=5&&1FQT4S$;EN,:!*O?FH*;`47:[MF
MTDE=NO=);^_56334*4MZ4W(\>3W!C"EVDGWGKC4H8V*,@G,;O<#;,=E1@Q>N
MC"83&7GH$C&2$1ZF\WOJ+!PH4XKHL4:(D_\`++_E6Y,_^'W,O^[NQ:*C-0'O
M2J_\PSAM_P![49_U<GM4K:[)>C#J+2FK?6AS'7L2>GCG9E*R*+:>RU%,<0TR
M-%0@.IB7M\BV3EB-T1,"JB475&S]XN8H"!$T>NW<&Y9-%2HWGH5<0;CF_EK6
M.0#R)>-,0<<7[NQOK(NBHBQGLDJQ+MA4Z?#N#$\-\^C5)+\T?^&)@:H-TB*"
M4SE+>K-QH**<L&WO'8OM,(]`*4.HF$1Z``!UU%J7FN<[\^RW)KEQGW,CERL_
M:3U_FX6E-SG$Y6E%J#E2K4>-:E]B::D+%I+&`H`!G#A0_M..JMXP%%Z`7"O!
ML9QNXI8%PQ&M"-5:;C>O$GQ*4I3O+C--"3]TDEM@`3K2%IDW:HB.X@!@#V`&
MHM)-2E0:*(T1&B+C8-]]@[MMN[8.[8-Q`HF]HE`1$=O9N.B+G1$:(H]?JJR[
MCESS/X6>F?6W*KFNR-O8YYY#ILE`,5K3X-*17CHQ^!>WP5"5*,F%^PX["M(,
M3!U$NJ%FW`%RU1_,=<<FTCBG!7)6MQ2*"F,9Q?#UL\FB!"H4JXI_F--.9)(@
M)HL(*SQ2C5/V%*:6``]N@58>"N'\N'R,_4>)\R<7)M]XDGC"PH9/HS=90QE3
M4N^*^2LS)L4PB!6T)<F0.#``;`:8#Z]"H\<5);U%@JJ/X_W#HB[>B+3?(;_L
M,RQ_]B6+_P!G+:Z0]Y7'W?\`>/\`QZ]_L7+DNS?]UZ=^UQ_E!,U8Z/7P52\X
MA,F(`E'9H\8$-MTWZKL%`W]ONU\->D<FUQ=M]NBU`CF_HY8!AY70G%>RNOB\
MY"8S$#WM=^XY+LHJ^*P*CYV-NHC]W?OD(E5$>H;!VMF[-4?V;Z^CVQ[GI".0
M:C:Z\7T&)FMW-^!C(G?A74&J,U[Q>J?;?P7@_A+EKOD-(A&9AJO:F[;03C'D
M$-?3?`L19-L22ERNTU/,&,H"Q7(@)]Q$=A+[MM=4>\KJPT;KOHHY9HMMS;7M
M19ME#PYK!/<B5KN<D\X>07`FM"TY$%>=V9;^T;7N,0Z[;>O]86TI7E93+A3+
MOJMQ8]N;9FDB8%"]"E'?</;M_HUW9TZWM!IS&/#A4!<8UC37RO)H5FMEO!9-
M1HDW-W.E'31)N!/QBN==,J(%V'<3"J(:YUNKJ"=8G@BMW<UXZ:-K`,R\O:&T
M\]*+QEEI7J&N=(*,#237LH:KZR<KC9*2DB2\;;33`K'%XHQ<(-D5%AV[E$1D
MO'`R!A_`)2=FWLZ:_7U7FZ71:Q=,UBUUEVM<Y]88GL8USL?$WUY?5A/HEK0V
MGHX*:$-:=`SV9]O[-3#F!)IV>&F/;C7M2$,DJ4XQ5OR]I9TPV/V^=D8A3Z]M
MP0C2#T_?KYZ=89=D.A?[##JS?":>LFMCPX\L`^-=M;?&I@M]:Z`^1KQ\;EOK
MT_A1$^7O+E5*F*]/W!4Y%#B;LG]Q[B)IAVC[NFO8/[M(V[H-Z&V#VQ>OTW!Y
M#C7DO*XAK13S+B_6,/`TWGIS<LV6'&/RIQW7U)72"-$2'O4;Y-I\2.'.9,OM
M':;:WE@34S&Q#'$JKC(EU[X*M*-P#JH:&.X4DE"_]`R./NT6314IGCT@^8GI
MZ\0N'L#7,E<IL:0.9LDV6=R9E9A(FGEYB-F918L9"04F[;0SE-=U$5N,;"L`
M*'*#M=<0$>X1&K)P)*U=ZV?*K@9R^XV5!WAKDACB\9FQ)D!E-5JNQ1II.7G*
MI:D0@+G$,3/89H@8Z7^!D1*94H"6/-MN80`2-!!QR6L_Y<?D9^E\QY>XOS3[
MLB\J5U')=(;JG,)0NM%3*PLS)J03=I5YFH.TW!M@W$L2/U:%'C"JF"ZBUHT1
M)_Y9?\JW)G_P^YE_W=V+149KST^!R^6&W+CCBXP2RJ$EF)&^,%,=Q]_7>MJ4
M\L)8:4[$+(XC5$7Z,:9EXVYD3`H!^W;ZM5;C2F.2DC\P/4A]8'AK7(R9S+Q@
MXSP5:GGWY-&Y1IJETO=00FG"9U&D5)"A=VJD))N"(J&;IOD4".A*8$C'$HAJ
M+6`TY)!_"H(GUE^4\G'>H%GZ]2MBI5?-8\386J*,11J):()!01N43`N6)A<0
M3R+(DS6>(M$32TDQ$ZIGX%:F`M61\(P4QK&F,,>8:I$!C;%=.@:%1*NS*P@:
MQ6V*;",8(`/<H?L+NJZ>.E1%1PY6,HX<JF,HJ<YS"88M6:N]S%X6G6XT=W_F
M`5>PBQ\/?O\`.!$/!:]G;][O\?MVVZ[Z*C/%>7A3?#&WT[\Q[?!&X5<9'Q=^
MT4QL$?Y[Q=_X.P3]V_NWU5N7J:#V[_<[>S8O9V[=G9VAV=FW3M[=MMNFVHM"
MXT1&B(T1&B(T166RV.$IU<L%NLK]"*KE5A):R6"4<F[&\;"0;!Q)RKY<W\*+
M1BU44,/U%T11+O37YQ<577+[F1SLY:9SI>,;]E29)3L/U6V'E7$K#8U<.&[T
MZK<K.,D`:-VE=@X&*2'N*<QFCG<``^YJMK@:4"<SYC^H'Z8?)_B[G#!+KE_B
M<SK(-!F(^O++?J4I&-RCR$FJ5)"<:\/8$?:XUFJ80Z]A1#WZ+$!P-5%K]*[D
M@/&+G#@V^R3XK"H6N9#%&0SBN)61:GD@[>%%\Z.4>T[6`LHQTD)AZ`5H(^P=
M%FX5%%Z)HAL(@/M`=M1:541_'^X=$7;T1:9Y$_\`83EKX4*R#]D<MKI+WD__
M`(#O'_CU[_8N7)MF?[LT[]LB_*"9%H2Z'C(G=/4&*`B&YS%.Z<&`/:"+-#=0
MQOJ[Q3)_K!KX"].)+>WOV/O[F*VM"<S61YX'EB9XB>PO+&?7"]I=:8\L(B87
MR=F0\[CA\%3W)=-"OM?KA$58&OI2$D4"]LY:%0=*(F``^8QAF9DV3+8>H&.J
MX4#^L&OH_P!/^HFW-MP1W6W--9<ZJT#];OCSEI[8K:,B*+N<Z25_UADNGM5T
MF[NW%MW,60D^A$*5[G//B=Y@T=RW!E7&Z>8Z=7D[;/M8#)1W@O:,X(P[E6;:
M0(DF,7-,V9?,_D\J9(AS&'[[<X%,7N$#$'M_K#TK@ZY[%TRWWOJ4.G=5'7!E
MTF1L/BA;,&M]1<QQCG-M<%K7/)\<3N1[2XM>QW@-O:Z[;&J3.T^%TVB<O+..
M;`EIKS1EV'.VI`X.%0:5!"96>*.0U7>'BG%&<2H-S>'^9PTO#O8TQ`#<JIEU
M'S95J0Q/O;+II&`/:`:]4;#I#[S^SKPZ)>[=??QQ'E%Q:W5M)`1F'%[YHWQ@
MC&DK&.`-2%SJ;7MEZA'[1'=B,N%>1['M=Y*!I!Q^B2.]*8QKC>1K<O%S.3Y5
MA$3;E%=:JPA%B/V;1^4@)H2,M(DWCE'#914#(($.<@GV,8^X`&O;'I9TSU':
M^L6FM]5[NUL-P3,>ZPMFN$T<4P`#)KB<?8.>QS@8H6.<PN\3GDAK5P/7-:@O
M+=]MH3'RVK2!+(1RDMS+6-](`TQ<0#3(4JK=D+($DW</*W?Z]%39V!A2!<`5
MB95$@ANDZCY1IW%!)<@@<NZ1TS@/4H^S7C^HO435H+N?;'4;3+._DMB1ST=;
MW#`1X9(9XZCE>*/%8W,=AS-.(6W2-(A<QM[I$TD0?PP>SO#FGB,CB".!"0KD
M=W"N!7/"OW!"F$=H^9*DB[3`1_`F_;CY!X4/ZQ@;F'^IKYV]7]0T&\?(="NI
M&@U`AN0UD@[FS,^QD\KO4N/T*KMS0(;J,`73`2/G,Q![RT^)OFYAWI3GIY&$
MX9@$?:#FG`/7?KX=@W#ITZ;Z]N/NR019;SKG[1IWY%VN#]:!1VFCZLWQQIRC
M7U071J-$48_U8)U]S3]0GB'Z;U3>.%JQ7+#%Y"S3Y`QS%;+3#-29D@>`0W8"
MU7Q+&.UDQ';M5G"!^+;56QN#:I_-+BAQ902301XTX!*BBF1%(IL.X].8J290
M(F43GKQCG$"%#J(B(^\=185*Q^Y<,.*UUJ%JISKCUA&*;VRMSE;6E(?$]"CI
M>-3G(QS&&D(J0:0*+IC),0<^*@LD<BB2I"F*8!`!T2I7G]8SM-WX%<TJ[/2:
M;E"V<9LXN(FULP%1(\K%5B==5RX,1`.TQVUDJBCH">XQ')3![M5;LQ1>D;!3
MD3:(.%LT`]2DH*QQ$;/0DBW-W(/XB89(2,:\0-[#).6;DARC[P-J+1E@KKHB
M3_RR_P"5;DS_`.'W,O\`N[L6BHS4![TJO_,,X;?][49_U<GM4K:[)>@?FS#=
M"Y!XGOF%\G1"<W1\B5Y[7IQH;M!P@1P4#LI6-6,4_E)F$D$TGC)<`[D'2)#A
MU+J+4#0U7G=9;QSF[TYN7\A6$9=Q!93P->6%DH=S;H'29V2&(J+^HVUL@;8C
MN!MT$IX;UJ(F((*.6:G4APU5M&(4^/A'RUI/-;CM2<YT_P`!B^E$!AK]4R+>
M,YHV0XE)`EFK#D1$5#-TEU2N6*INKF.<(+=.\0"+4X<IHE:;%'H8`,4>ABB`
M"!BCT,40'H(&*.PAHHO-(YK8,E^-O*S/V%WJ"[$M0R/8EJNL=,4O-4ZQ.SV>
MBRK8.@&2<5N6:F`2]`4*8OM*.JMX/%>@GPGSK%\E>*&!LT1KHCI>WXZ@`L1"
MG(=1C=(-J6OW6,7`IC"19A:(MT38VPB4"F]@@.HM)S2I-%$:(C1%AMSR+0<<
MHU]Q?KG6:8A;+3#T>L*V:98PQ+!<K"HHE!U>'%\LC^83LL=(X(-DNY53M'8.
MFB+,O9T'IHB8X]>[DPYP[P^1PM57*ILA\HK"3'[)@R,;\R-0HH[.2O2C<J1O
M&_VR9=A"@';\P)4P!U#;0+-@QJE></\`T_\``N$>,>%,97K"&(KA?*[1(@]\
MLEKQM3+%.R=WF2&G;6+J7EH9X_=(LYR27;M^]0?#;(ID+L4H`!1SC7!*2_X5
MN+O_`/->`/\`]-XZ_P#QS12I[5!A]8/C2TXR\Z<HP-:AT:]C_)K>,S!CQE%,
MD8N+C(RW`NE/1,*U9D2:,6D#=8R13011*4C=N*(%*4.T-5;6FH4S7TW^1Q>5
M/"[!F67CTCRUGJJ--R%LH*BZ=_HAAK%E6=;]2*R[B/+(%`?:B\(/L'46MPH4
MN='\?[AT6*[>B+4V>6#F3PKE1BS3%5RXH5G!),H;F.8D2Y5$I0#J)A*0=@]X
MZZ@]X'3KK5^AV[=.L6\]W+M^^#1Q)%N]U!VD@8#B5R':4T=ON?3YI32-MW%4
M_OP%'NAWXME2&`=BCL8!WV]NPZ_FRM[AUO(RYBX4/F7N1<0B1I!S2J,=W1G`
MBWE':2+^23[%(B/<`"K-!4/[J5E$AZ+IH#]Y!L/14^QE/E@!5/;GI/U"L=N"
M/4]0:R?50`ZV@>.:-IS%Q<-^<&G&&`X2.`?)]F`V3KG7-)ENRZ"*K(/GN'I$
M<6L/`GYSN`P;XC4*=QO>A7L3VY6!XM(_D3%U..EG*HG6>R2FS&(9@<WL%S(.
MR=I0^Z0A#"``!=>WO3#?;;K<L^^=?N'W0T^WDNI'/=5\LY`BMXZ]KYI&\H&#
M6M=0`-HN`:UI7)9-TVT:&>M>(Q08-:/$\^9H->))':L_KF1EW==RD[>NO$>/
M8M@\.<1V#QG<F6-4*3^J0B;P"E#W%*`:["VSU)O+W;.[KR_EYKVXM(92>UTD
MX@<&C@`V4-`X-`'!>'O-'CCO+".)I$39'-\P;S#XB2L8F;R2Q8^*W<+`>4I3
MY$Q#&,`G<5R5V:`?KU,,;(%13-]1%"?'7&-;WT-S=-A;W;ZZMH5PT@DXOLKC
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M`!2C]1:T:(H/_P#,#X&9XNYK1N4(=!%"(Y#X^C[6_123*F0EUIBB-/LQQ('M
M,_C$8MR<W\:RR@^W?5"VL-0GUO0NY8Q&>^'-=Q++SB#C*G&\A:#-Q+ER!I9[
MC\BJJN.;,DBH;Q7$:2%,$4=0H"";B.$#["<G=%B\8U3U6BP2<N8<BRB.)/*&
M2D7*31DUX]YC.NX6.5-,@'Q]/I$W,<2E`3J*%*`;]1$`#KHJ,U`B]+9VVCO4
M'X;+/ETVJ/\`G'7V7B*F`A/-2,3+1K%#<VP>(Z?NTTB![SG`/?JE;79%>C5^
MWH/U:BTIBOUS.!YN2F!29_QW"B\S5QZB9&2<MF*`J2-XQ&!C2%IK@$3(*CR2
MJI@/+QI.IA`KM`@"=R&J%FPT-%'9](WGVMPEY#M6UPEE2<?,RK1=9RJW,HH=
ME67H*&0JV46Z)>XI5*NNZ,E("4HF5B5U1V,=%$`+-PJ%/P9/64FR924:]:2,
M;)-&[^.D6#E%XPD&#Q$CAH^8NVYU&[IFZ;J%.FH0QB'(8!`1`=1:4PGZVWIJ
M3G*2H1G(_!D$:6SMBR!4B;-48Y$OYEE3&S55S()LXHA>T7MUISE=99@B/S'[
M1=9L43*E;$$LV.I@<DT?Z*GJ41/$N[37&_/,L>#P;DFQB^A;),>,V;8@R>H"
M<8_-.)K@4\74[6#5)"1,<I0C7Z!%U`(FHZ.6K)S:X\5-?:NFSYJV?,G+=XR>
MMT7;-XT63<M7;1RF59NZ:N$3'1<-UTC@8AR&$IRB`@(@.HM2KZ(K9-34-6X>
M3L-BEHV!@(1BZE)F;F7S:,B8F-9(G</)"2D7BB+1DR:H)F.HJH<I"%`1$=$4
M6U?EW'^IOZP?%B@8X<+/>-'&.T6S(]<>*HJ)-[Y9J/7W\J^R6X:*I@HG%KS[
M.-80I5B@H#03KB"9G9DR5;*<K3VJ5*(@&YC"```"8QC"```!U,8PCL```=1'
MV!J+6HDKC(%=]33UT<>Q[*1;SV!^,HR2]6[#(NXJRM,+JGGY6::$`?`>,+9E
MQXU*54.X'$4S1-U+MJK9DSO4ML1W$1^L1'[=1:UQHBCA?S'>!V=FP!B#D6Q0
M2)/8FOIJ%.+%)LN[IF3$/\,"JG\1(FVP33PB_P`(/E1]XZJS8>"2?_+J\LH>
MGW7*'$:YSJ,:WR8Y:Y)Q&G(.BH-7=VB8\L3=JPP\38@RD[76;)ZW2`0%7\L<
M;;G$`&<57CBI>2/]YM[P`0'X:+6NWHBI+IIK(+(K)D525243524*!TU$SD$I
MTSE'H8ARB("`]!`=8211S1NAF:'PO:6N:14$$4((.!!&!!5!+2'-)#@:@IA[
MDMQ\F\+VQ\_8,G#K',T^6<UR:23.HA%^94,K^G950H"#1XQ,82(F/L5PB!3%
M'N`Y2_S_`'O2^[?KO0_=]QJ.GV\DO3*^G<^SN6@N9;^L)=['<.'\W)$26Q.=
M1LT0:6DO#VM]L]B[RM=SZ<R&9[6ZW$P"1AP+Z8>L9VAV;@,6FM<*$Z`CYA9H
M<!$QO:`B;<>H_6.W7?7JW;W-Q:2^M@<>;RKF<ULR44I@MLQN0%6L42/(MMYI
MT1\]$#;]PM2*-V"!]A]B(*JJ;?6H'U:[8TKJC>:7HL>E!YK-,)I:'\V',A8?
MQ>:1Y':]IX+C5SHC9+DS$>BVC?/0N/GHT>8]JS2*R2+>*L:'C"`/H^/0$.X>
MHI33!T7?V@`;(C[==A:-UEDM]&U6!TA'K[:%O'YMU`_XFE>)N-OA]Q`^E>5[
MC_$</W5CY,CG:KF-XHF;NF[A@]3`?[QF]3%)8/B*8[*%^HZ91]VN+1]7YH+H
MGF<ZUFB?#*`<XI6\KO.W"1OUV-/!?N.@->P8>-I#F]SFXCY#W$K5,Q8EESJ$
M\7O$IC%W*.Y3;"(=X"'3M-MN'U@.NG]5UF^U&9[97U8'$5!J#3"H[CP7);6R
M9&`:+K5.HVG(=C8UBIQ3J<G9%0$T&K<HB1!(#`"CMZN(>"PCVI1[E%E!*0A0
M]N^P#Y/96R-U=1-QV^T=F6<U_KUPX!K&"H8W(R2O]&*%@Q?(\AK0.)H#=2U*
MPT6R??ZC(V*U8,2>)^BT9N<>#1B4_9@_%+##6.86E-5DWCY'Q9&?DTR"0LG/
MO^P[]RF!OO@V2["HH`/4$4B[]=]?T0=!>D6G]$>F=CL6S>V:^CYIKN<`@3W<
MM#-(`<>04$<0.(BC8#C5>H6ZMPS;FUN75)`6Q'PQM^C&WT0>\^D[ZQ*V'84Y
MY6`G$JLXC&=G4AY1.N.YINX=PS2>.Q7+#.9=JT41=NHM"1%([A-(Y%#H@8"B
M`B`Z[D7'%'PY%>EOZE7-&/807)KGOBQ2HQCI&394#'>*;!$T<LNW*?R\@\AF
M\C759MVS%4_@+2"SHZ'<(I@01$=7!9AS1B`L6XY^C[Z@'"V:G)OBUSMQE`EM
M:3(ELKUIQ/,O:G8S1H+A'KR<`]D;,U%\P*Z5(B[1\!T0BAB@?M$2Z(7-.:D"
M8;CLL1&+Z5&YULE1M^76<.5*^V:A0SRO4^8F_,N#"Z@8:045>,68-#)$$IQ`
M3*%,8`*`@4(L32N&2PSDK`\D;'C)6,XJW[&^-LK'GHA8EFRI5I"WU=.M)BX_
M/&9(F--XQ9=P!DA;JF*HF7L,!B_>`P$%*XY)@S/WHJ<Y^8%X:9`Y.\Y\;VN>
MBXU2'@B1&+)I&%KL2HN+I2.@:^P?UF,CD'+K8ZQP*9=8P%%0Y^TNQ9AP`P"P
MC'GH`\J\#W"+R3@7G77*-D&'!5-C8(FA6RNK@U7[0<Q[PS2SS3>5BGH%`%VC
MINLV5``[R&V#:U3G!P(3YW&VB\]*CCO*$)R8SIA+*^0G,:5'"]QI^.I.L-(6
M3"#E$/-Y&BT2Q36=:_GQV2WALD4#B@FL43B)R=L6)Y>";%SYZ<?JM\LZVM1<
M]^H#B1#'\AX!IBBXWQC.UNL2HMUDW*24PVC$H*1L#-%RD10J#UVJCWE*82;E
M`=54.:,@D=I?RUF5HU9O)0O,.G-)>/<MWT8[0Q;9XQPS?LUB.&CQK(LKTH[8
MNFCA,JB2J0>(FH4#%$!`!TJKSIW3C'Q\]5G$=YHC+,G-3#><\)P[\Y+C$SV,
MY(,G2L$6/=)((1%R(R8.CROGA1.+A^X<CV$,)A4$VVBQ):>&*=D$"F`2F*4Y
M3`)3$,`&*<I@$#%,4=P,4Q1V$!Z"&HL5%FY!_P`NK.W_`#WD2Z87S3CW&.';
MA/K62!I4Q5K'-35/7F?\;/03!./=,(M2`:3"JQHTGCE.BT.1$P?+`QK5;`_#
M%**P9Z:/JA<3H)K5>/GJ+T9Q2V29BL*#DS%DS8Z9&`8QCBWA8Z7D+8Y@&9CC
MN*;!9JF`B(@3?J,4+FG,8I^>C-[BSI50:9"DX69O[6LP3>[S-:8N8NNRMM0C
M&R=ADH&->*K.X^'>RQ55&R*AS'31,4IAW#188<,DV/S;]'?BMS.DY.^':2&%
M\SR?<K(9+QVT8`C9G0@4`<WNG.BI0MG<B`??=D,SDE/89R8```+(.(\B0OB#
MA7ZSO!!NE4^-F>,'\A\/,%3!#XURF]FXYG&M`4.8C>'86!$'M03.!A$6\;8?
M)`8VX);]=59$M*5&.;O70?HC'M^$W$>`?B04QL,IFU:0AR*&#;S"42PMZC\2
M$'KV"<VHI1G:DL9H].'U:N<[9**Y8<NL-8[QT=RDY/B7%L;9Y"K)J)'%5`\E
M"1K&LM[.X:&-ND:4E'X)FZDV'KJJ\S1DE;>G;Z/%/X#99FLS!FJ;RU:Y?'LG
M06[)Y28VIP\(E,S,%+2,I'BA.3C]9TJ2"(W[5#@7PU##[=18EU115^6_$7U.
M.3<WDFE0?-3$V'..=KE9%E"5"D8YL36^K41TD5NG!W&WH.&TH^=.VQE"/2,G
MS5NX`XE$/#,)`*@M'#%-WXN]`;E+QZO5?RQ@3G%3J;DJJJ.!A)M#%LZP32;/
M&YV;Z/>(GLD\RDHJ1:*&2<-'#55!5,=C%'8!"J\X.:?UXHU/F'4:S:6/,/+6
M)<NV96;9*4R;Q31G]'19U]..*F_1L;1T"+9W*.9/=0@MT4TTT^FX[[%BP-."
M45;D+.ZJ=H:TF0BHFYN:[-MZA*SK-:1@XRT+1CI.OR,S'-E$7#^)92QD5'**
M9R'51*8I1`1`=%%'^Y)^F;ZH7,ZO1=+Y'<Y\'JT6-DVTX6E4#$T[!UQ6;:$5
M(TDG[=M^4OYQ=@"YQ;@[=*)HF-W%(!P`VJLPYHX))3?^6QRW#.FDQ7N8U183
MT4[;2,/(-,8VF&>1\DS6(X9OF4K'WI1]'/&BZ93I+(AXB9R@)1`0WTJKS_`G
MG^'&"_4QP[=H2,Y)\M\3<@L*1T',,G+,]!E&.65)06Q"UYR6Y'9,?/H-7)1%
MT=\=TNL0=NX3??U%B2TY#%.D:+%?)_P&_LF_H'1%9G[!A*LG,;*,FDE'/$C(
M.V#]LB\9ND3?B2<-G!%$5DQ^HQ1#7XM1TW3]7L9=,U:"&ZTV9A;)%*QLD;VG
M-KV/!:X'L((6R&:6WE;/`YS)FFH<TD$'M!&(2:YGAQQZF71WAJ.>*45,)U$H
M*<F8MF)A'<1(R2>&:H`(^XA2E#ZM>KNN>Y)[MNN7;KUV@>R2O-2VUNKF".I-
M<(F2^K;Y&-:.P+G-KU,WG:QB+VOUC1QD8QQ_A%M3YR5:`X1<?"_AK]@#]EMF
M@_H7UX,^X3[MISTR_P#^H7?]XOT_^U=Y?GHOT3/D54.%&`2E,4L'8BE.``<H
M6V8V.!1`P`;=4=]C``_M#63?<+]V]K7,;IFH!C@`1_J%W0@&HK]IC0BOE4/5
M/>!()FAJ/ZF/Y%3'A)Q]-^*`L(_MMLS^WV`L`:P'N$>[8#4:7?U_;[O^\5_]
MJ[Q&4T/Z*/Y%](\)./*2A5#5B:7`H@(I+6N<%(VP[[&!-TF80'W]=;X?</\`
M=LAD$CM)O)`"#RNO[LM-.!I*#0\<5B_JIO-S>47$;>\11U_)6_Z5CJBXZ8'C
M*/5H>M-%>T7'Y<U*5T\$OX3/GZHJOGQB^X55#[>[;7L9L;IGL#IGIYTO8>DV
M6EV;_3]3&`^2F1EE=S2RD<#(]Q"X?JFM:MK4WK]5N)9Y!ES'`?BM%&M\P"S3
M7.5XM&B+D`$?8`C^P-$5LCYB(EC/B14I'29XMX,?)!'O&[SR#\J2:YF3P6ZB
M@-W945B'%,P@<"F`1#KHBN6B+D`$?8`CM[=@WVT1<:(C1$:(C1$:(C1%;I67
MB8)J#Z;DX^(9F60;E=2;Q!B@=PY5(BV;D5<J)E.NX6.4I"!N8QA``#1%<1Z=
M!]H:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1%51_'^X=$7;T1?)_P`!O[)O
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M2$#*J&[3&'J`%(4QA$`#14`DT"RJ%E6T]#1,ZQ(Y(RFHUE*LRO&YVKL&L@V3
M=-P<ME/OMU_!5#N(/4H]!T45ST1-IVFIQF0>=$)7V2\O(1%*:L+I;6\E,R,S
M&MYF-2&:*C'LW[APWB6IG;Z-1%NB!$BF$VQ0]FKP6RM&)RT=_:/M'K^W?WZB
MUKC1$:(N1`0]H"'[0VT1<:(C1$:(C1$;:(C;1$:(C1%R("'M`0W^L-M$7&B*
MJC^/]PZ(NWHB^3_@-_9-_0.B+HZ(C1$:(C1$:(C1$:(C1$:(FR.2]J<9!Y*8
MWQ?#PZUL0H2J$JO6FZ@)HS=M>)IRY6,BZV,DPBVC)LU*\<'Z-VQUQZFV`:MC
M105*R64?9VHO)C"T39<JKVP<AG=N+!485JK&5*%C$O,HOF3&*.LL#IBT1(*B
M#Q8I')CH&,;13`M)2\;5)S,1!NWE=@5;+.B9NUBH@CA-H@L\>N$VJ+B1>JCL
MRB&(J^,Z5`#J$0(;L(8^Q1BP2),`V?*-[Y%9*>O<AREKQ]2F+B#D`22".J3N
MQN3-T$FE?A4E%D$&D>]9NS(+&.=RHW3(94YA5T69`Y>]*DS7EF&PMC^5NTLE
MYQ=$Q&$'$@IX1YB<=%4%FR!38120*5,RJYP`1(@F80`3;`)8@5-$E"U*Y?@,
M"36?;GDBTQ62%DX.PUJK1#X(NDUEC*3$:C'U]Y6"$.UFU7D<Z'S(N_%4*)@*
M!@,0QC59BG-09):N.[2>[T*F7!1N5HM9ZU#S2[8F_AMW+]DDLX23W$3"B1<Q
MNS?KV[;ZBP(H:)`W))Q<LQ9KQIQ^D&T;!P3B9-8W*4/(GE9I.'3%^W--3:IV
MZ46S<&A&+EPU:D(MX0+%\4YC&[2U9MH!S*_-YZ[X2Y4T;%B.0[A>Z-?(AB*T
M7<Y!*7>12KXLNV059.2((%;"R<Q!#E\(B9!0.8ABCVE-J*$<S>;BG`9&0:1$
M?(2T@H"#"*8NY)\L;\*+-@W4=.5#>S8"(I&'18)J[C`YO^2K9EZW5!P2OV*^
MV`3V+(3UB603I-67<N),D7`,7':VD[9,JKI)HD4'P&39EXJ@")DB#2MCJ4%5
MN#CG9,C1G(W,&);#?;#D&M5J-<NTI&R.!=.VSYN]A@:+I&$!(S.NC*J(K))"
M5$YD@,4H=NBAIRUXI;=LME?HU=E;7:9)&*@H9L+E\\6[C;!N!$D&Z1`%5T\=
M+&*FBB0#**J&`I0$1U%@!7`)*^5LB95B,3V3+KNP$Q&P;L43TBDA#1$Q9Y1U
M(K)H0_ZS?RZ;M!B]D2*>*:/8)D.R2`147.<ABEJS`%:+8G%VN6F!P_`/;K-S
MLY9[<=6WR"D_)O)-TP1F2)'C(Y([U98[8B4:FDH=,O:`+*GZ:BCCBDV<R\E9
M1JK*.&,M4GCAB\M*\36HR$<(IS-DBX=B"\S=9J49JJ.6,2G(.FZ#!@GL*I.]
M5QN)B)DJK0"M@#2>361'V/<B,\G?H6*+(0[A:@J$=-%"5%#RRAY2P`U35;S=
MGLB":BKADN0B+0K@B93@8A]1/",$JR[2EDC(8!J,2A)STB^0C6:L@H",'`IN
M"JJ.;'8E`527&&AFR)E#I([K.%.Q$HE[^\I8)NG`>1LU9$RCE*&K.1)FQ0KD
MYFS>YV5FW4@JG#HRRY2VF,K:8EC$9J3:-Q1C6"9BH;*F57$Y$![JMA``J50P
M)D/,UGRCE&CU#(DY=((ZR[9E?;F4LE'52+93"R*MQ1C3"5H:3D&29T6+%,4F
MJZIRJJ%!)$X:8(0`*E;4XAV#(5GOF97;^_V6_8UAI'\CK\Q9EP5/(S*<BJHF
M^CD"AX#$AH@@F530`B/:NB/8'0`*.I3O2V;-9H*FP$K:+-)-XB"A&BCZ2D')
MA!-%!/8`*0A0%1=PLH($22(!CJJ&`I0$P@&HL$EK)&1LFM<5V?,"T]_E#!,8
MOS=&JJD)$2]MGG3PQ$8`]Q7F4W36*/,KJD,$:S2!=LB83*N!.4Q"ED`*TS67
M<4H"V1>(HJ<O$[/3MEO+I:X.33TF^D5X]A)$3"'8H`]65\JFI'ID<'(0"`!U
MQ#;IHCJ5P2E-%BJJ/X_W#HB[>B+Y/^`W]DW]`Z(NCHB-$1HB-$1HB-$1HB-$
M73D'I(R/?R2I#*)QS%X_43(&YU",VZCDZ90Z[F.5+8/B.B)MCBE:Z'$Q>5N1
M62;)$-;5:;5),4D5W**\VBQ4%M**1\+$D.>1>/)IX]312313,90C8A0Z`;5*
MV.!.`2CL0T2QV?(,]R&R1%N(6=FV`0..:<^$#/:52";^$M*%Z@A89M,PG63#
MJ@550!^\<2EBQ)`'*%>^4V4U<3X@G)>.4,G8IXP5:M&(.RC>1E&[CS$B7J`@
M:,C4EEB#_P!*!`]^B-%3W+%>(D1&5C'J%:@F(R#5%!"8L]]2<)GBK#>98"JR
MD)!F`AE)=G56!$6JKTIQ;^.0R9.XX*"4C\U@?,J!=66X\:X-V4XU66R0,7+&
M-N#7SSUW!$;HN#C\LIW$:1T5/N]H"?;WZJK<B0OCE9)2.7;)4^-&/#%>RCR4
M:6+(#UK\QC4H-B(DCR2RJ(BFV,GXQG(HFV,(IH$`!,H`:#\"-P\12W(&&CJQ
M`0U?CP!"*KT0PB6@J"4OAL8MFFU3.H;H4!\%'N,/U[CJ+!(#XS2\;D_D!GO-
MTD]:%:PQ$H2OG>+I)$C8!RJNV2D#J*F*5NW+"5X@&4'8@>.IUZCHLW"C0.*R
M;%E?5S5R.L_(@Z*H8^J:`U+&;IPF8A;(Z8,UHMU/,"J%`QXEN=T[435V`IU7
M!`+U3/L0^%O+Q6Q.95T5J6#IV.8'-^=7UZPH\4@D?9=8)50590J10'N,)XML
MJET_B5#Z]`HT5*^L9S>'^.E-C,4S=P@HNXP%7&YV^-55$DB_D7K8KZ3<$$4R
MHO'JQMD6C4AS.%$$TP(00VT0@N-1DJO&G'$Q!HWC*MR8J1UWS'87-F<Q3DNS
MNN5M5TY=04(Z`0[DGPI.O%<$]I![$S!W$'10G@."U/G'(U7><FL98^R!-,H+
M&]%CQO\`,#+*@A$R]O,R?NJVG(F/NDJWCP;IF1(8!`ZRAB["8P!JK(#PDC-:
M5S5DM'-6<J13[2HYJV(JUY>X*,)1)=I+6./\J>3(^7AQ3\^>6M;)-)K$QX)F
M=>"\*;L`ZQBE*@4%1FG2*U(OY:`BI.3@5ZN\?-"N#UYTL@N[B4CF/Y1F[,V*
M5NF\(T!,54B;E14$4]S=O<,6M($L$(GR%YD&B71`>T+!D8Q+,)F^^T=S""X/
MS1IP'<AC/K"L1)8H_C0CU`'IJK8/"WO*<7$=QW'WZBUI*7,#);FC8L4KD$=0
M]RR<["F5YJV$?.>7?]B4RZ;E+][O%JN5JF8.H+.B#[M%DT5/<M.WB.;<4>,C
M:AU\Q%\H9-6)`K.60`+]_/S+=-"<=,Q*`JF:P4:H#%EL(=JJB9MNXYM545<Z
MO`*UWF+0XF<74J=%'2+DS*:Y8B6E$#$3.61?L]YPZ+H0#PV%?AS^2;&$P`55
M;Q>@G-IFJ/$ZO`)2?&")BJSCEG4JXP%Q`0)$2K7@BI`CKS;GH*.+:]@4@3!5
MY`Q#P$V;=_W>"Z\(2I=Q$N\Q8NK7'-:;Y!Y!K3KD-B/&=]F6D%C6N(AD2T*R
MBH(1,M/(H2JM79RAS[HG8LW,840*<.PZJX@/4"[15HPJ,UI+/F3T<U9@H5%G
M7:M2P[&';VYTI+%68OK'%%0=/3S:T8)/.@M.QK0[:%9"F+I4KLJ@)]ZY2%*M
M%!49IS^IR+N7KD3)/:ZYJ:KMJ"J-=>G1.]BV'><D8@](W*5%H\-'%2.JW#N\
ML<PI"8PD$1+`YK(M%%51_'^X=$7;T1?)_P`!O[)OZ!T1='1$:(C1$:(C1$:(
MC1$:(@0`0$!`!`0$!`0`0$!Z"`@.X"`A[0T1:M@<(XAJ\^I::_CFIQ5A.J=<
MLJVBD1<MEE3BHHHQ!;Q4HXYC"/5`J8]=%:DK:6BBQ*XT.FY!CFT3=JW%V:-9
MODI)JSE4!620?(D.F1PGVG(8#>$J8I@W[3%,(&`0';14$C)9(R9,XUHVCXYH
MV8,&2";9FR9()-6C1LB4")(-FR!2(H(IE#8I2@``&BBMECK->M\2O!6B'83L
M0Y,DHJPD4"KH^,@;O;N$AZ*-W3=3[R:J9B*$-U*8-$5OJ5$IM#:.65.K<57D
M'JWF7PQ[8"N9!QN(^/(OE15?/U@[AV,LH<0WZ:*DDYK4W*;()<<81N4HDX!O
M+3;$:M!!W`58[^=*9HNL@`B!A,QC177$0W[?#WT1HJ5A6#.../&>'<>M;I3(
M::GEH<)R37?H'%4ZMB5++_EC[P5$BR#)DB=%,$'`*I%,F(@4!$=6JI=C@E9M
M6K5BV;LF39NS9M$4V[5HT02;-6S=(H$20;MT2D1113*&Q2E```/8&HL5:)NK
M5FRJ12MBK\/.J03\DI#'EH]L_-%R1``"/F/F$S^7=%[0V.78>@?4&B*QR.,<
M>2]N9WV5IM?D;C'I(I,["]CTG$@@5MW>5.4RG<D9PT`P@BJ8@JI!^$P;:)4K
M.M$6"3>,,=V2RQUQL%,KTU9XE!-M'S,E'I.G39%!0ZS<H%5[D%3-55#&2,H0
MQDA$>T0T5J0JR^-Z$ZN2>0W-1@G%W1;HMDK,NR36DTDVQ!2;F344[DTW""(]
MA%0*"I2?=`VW312II3@LUW]_O]N^B*P0U5K-=<S#R`@(B&=V%\:2GG4:P;LW
M$S(&,H87LDLB0JCMQW+''N.(CN<P^T1T5J5?]%%CLK4:K.RL-.35=AI:9KBI
MUH"3D8]L[>PRRADU#JQKA9,YVJAE$B&W*("!B@(=0`=$K1<R]2JU@D867G:[
M#3$K7%SNH"0DH]L\=PSE0R1SKQRRZ9SM53*($-N78>XA1]H`.B55NN./*/D)
M*,0N]7B+0C#/32$8E+M_,D:.SD*FHHF7N*!BK$*`'(;N(<`#N`=@T0$C)9<B
MBBV11;-D4F[9LDF@W;H)D10;H(D!-)%!%,I4TD4B%`"E*`%*`;`&B+"+!C#'
M=KL$7:K-3*_/6&%2*A&2LHP2=N&J*:IET4^U7=%<C=<YCI@J4_AF,(EVWT5J
M<E4=XVH$A<&F0'U0@GET8MT6K.QN6*:TBV2;]_EA2.IW)%6;`<025[?%3*.Q
M3`&B5-*<%F^BB-$55'\?[AT1=O1%P.VP[^S8=_V;=?9\-$5#Y'T[]$1\CZ=^
MB(^1]._1$?(^G?HB/D?3OT1'R/IWZ(CY'T[]$1\CZ=^B(^1]._1$?(^G?HB/
MD?3OT1'R/IWZ(CY'T[]$1\CZ=^B(^1]._1$B/.__``F?JEQ_G9^I?SSN-X'G
M_P#-+\HV\JW\3\@\E_\`+WA>#V^)Y+[O?OW_`'M]%F.:F"4AB/\`1OZ)C_T3
M^J_TQWC^4_J_]6^?\IX#?R_D/UA_M;\F\#M\OV_(VW[/?HL36N.:V9\CZ=^B
MB/D?3OT1'R/IWZ(CY'T[]$1\CZ=^B(^1]._1$?(^G?HB/D?3OT1'R/IWZ(CY
M'T[]$1\CZ=^B(^1]._1$?(^G?HB/D?3OT1'R/IWZ(CY'T[]$1\CZ=^B+[)X7
/=]SV_P#I?Z>FB*KHB__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
